Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

CNBC purchased what appeared to be Novo Nordisk's Ozempic from a company called Laver Beauty for a fraction of its U.S. list ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

Health-care costs are going up and and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Ozempic.

Eli Lilly and Novo Nordisk are already the biggest drug companies by market capitalisation that have ever drug companied, and there is reason to think they may be getting even bigger. And the reason, ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

At least 81 percent of Wegovy users, the version of Ozempic approved specifically for weight loss, identify as women, according to Novo Nordisk. And the large majority of vocal Ozempic supporters and ...